Galectin Therapeutics Inc · Brief

Next report

12 days

Nov 13 · before openest.Q3 FY26

Expected move

±43.5%implied · straddle

1.874.77

spot 3.32exp Nov 20ATM strike 2.5ATM straddle 1.70IV 288%

Oct 30 close

Expected move

—≥ implied

Q2 FY26±26.6%▼−2.55%×0.10

quarterimplied−30%0+30%realized×

Q2 FY26±26.6%▼−2.55%×0.10

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 13 report · est.

Bull2 of 3

6disclosed supplier and customer ties in SEC filings across corporate counterpartiesSEC filings

101managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear1

4 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 16 '26once per report · top 2 per case

GALT report session

No linked exposure.

Oct 30impliedImplied move: ±43.5% into Nov 13 earnings (Oct 30 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.